Clinical Guides
Cluster Headache
A clinically focused, India-facing clinical guide to recognising cluster headache, excluding dangerous mimics, and arranging safe acute, preventive and specialist care.
MedNext Academy | 13 min read
Cluster Headache
A clinically focused, India-facing clinical guide to recognising cluster headache, excluding dangerous mimics, and arranging safe acute, preventive and specialist care.
Summary
Cluster headache is a primary headache disorder in the trigeminal autonomic cephalalgia group. It causes repeated attacks of excruciating strictly unilateral orbital, supraorbital or temporal pain, typically lasting 15 to 180 minutes untreated. The pain is accompanied by ipsilateral cranial autonomic features such as tearing, red eye, blocked or running nose, eyelid swelling, facial sweating, miosis or ptosis, or by marked restlessness. A person who paces or rocks during a short, stereotyped one-sided eye pain is very different from the person with migraine who usually wants to lie still.
Attacks occur from one every other day to eight per day during an active cluster period. Episodic disease has bouts separated by remission of at least three months; chronic disease has no remission, or remission shorter than three months, for at least a year. The diagnosis is clinical and requires exclusion of another disorder. A first or atypical presentation must not be labelled after one dramatic symptom alone, because secondary lesions can mimic a trigeminal autonomic cephalalgia.
Rapid therapies matter because tablets are usually too slow. Current guidelines recommends 100% oxygen through a non-rebreathing mask and a subcutaneous or nasal triptan for acute attacks, while preventive treatment and its monitoring are normally planned with a headache specialist. This educational draft does not replace individual assessment, emergency care, Indian product labelling, oxygen-supply rules or local neurology advice.
How Common Is It?
Cluster headache is uncommon. Population estimates vary with diagnostic method and ascertainment, but a frequently cited order of magnitude is about 0.1% of people. That figure should not be treated as an Indian prevalence estimate: robust, contemporary population data for every Indian state are not available, and clinic series over-represent severe or referred illness. Under-recognition is plausible because painful eye and nasal symptoms may be called sinus disease, dental disease or migraine before the attack pattern is recorded.
The disorder can begin at different ages, although adult onset is common. Historically it has been diagnosed more often in men; sex ratios are changing and must not be used to exclude women. Most people have episodic rather than chronic disease. A bout is a period of recurrent attacks lasting weeks or months, followed in episodic disease by remission. This temporal structure is diagnostically useful but tells neither the clinician nor the family how disabling an individual bout will be.
For service planning, counting only diagnosed cases misses people purchasing analgesics, visiting dental or eye services, or receiving repeated emergency treatment. Conversely, not every unilateral headache with tearing is cluster headache. India has no single national registry that establishes a precise burden, care delay or oxygen access rate. Local audit should report its denominator, diagnostic criteria, setting and date rather than transferring rates from European or North American cohorts.
Risk Factors
A family history can increase susceptibility, but cluster headache is not a simple single-gene disorder and a family history is neither required nor diagnostic. Circadian and seasonal patterns are common, which supports a role for hypothalamic biological timing, yet the causal mechanism remains incompletely defined. Alcohol can trigger attacks during an active bout for some people, whereas the same person may tolerate it in remission. Vasodilator exposure, including prescribed nitrates, may also provoke attacks during a bout; this is a reason to take a medication history, not an instruction to stop cardiovascular treatment without the prescriber.
Smoking is common in clinical cohorts, but association does not prove that smoking causes cluster headache or that stopping smoking immediately terminates a bout. Smoking cessation remains important for broader health. Sleep disturbance and obstructive sleep apnoea deserve clinical attention when history suggests them, but a sleep diagnosis should be tested rather than assumed from nocturnal attacks alone. Stress, heat and glare are reported triggers by some patients; a diary can distinguish an observed personal association from a universal rule.
The largest practical risk is diagnostic delay: self-treating rapid attacks with repeated oral analgesics can add gastrointestinal, renal or medication-overuse harms without treating cluster headache effectively. First-onset unilateral autonomic headache also carries a safety risk because pituitary, vascular, orbital, sinus and other secondary disorders can present similarly. Risk assessment therefore includes age at onset, pattern change, cancer or immunosuppression, trauma, pregnancy, cardiovascular disease, drug contraindications and access to urgent review.
Diagnosis
History
Ask the patient to describe an untreated attack from onset to resolution. Establish side, site, maximum intensity, duration, frequency per day, onset of bouts, remissions and whether the patient is restless rather than still. Document ipsilateral tearing, conjunctival injection, nasal symptoms, eyelid oedema, facial sweating, flushing, ear fullness, miosis or ptosis. Ask about migraine-like nausea or light sensitivity without allowing these to erase the short, repetitive autonomic pattern. Obtain a headache diary and record all prescribed, non-prescription and traditional medicines.
Examination
Examine between attacks and, if feasible, during an attack. Record blood pressure, full neurological findings, pupils and eyelids, visual acuity and fields when indicated, ocular redness, cornea, fundus where competent, nasal and sinus findings, jaw or dental disease, neck signs and a Horner syndrome. An abnormal examination does not prove a secondary cause, but it changes urgency. Assess mood, sleep and suicide risk compassionately: intolerable pain can create crisis even when the headache itself is primary.
Investigations
ICHD-3 criteria require at least five attacks with the characteristic pain, duration, autonomic symptom or restlessness, frequency and absence of a better explanation. There is no blood test that confirms cluster headache. Discuss neuroimaging for a first bout with a clinician experienced in headache; MRI is generally preferred when a secondary trigeminal autonomic cephalalgia is suspected, with urgent imaging guided by red flags. Investigate targeted alternatives, such as eye pressure for painful red eye, inflammatory markers for suspected giant-cell arteritis or vascular imaging for dissection, rather than ordering indiscriminate panels.
Differential Diagnosis
Other trigeminal autonomic cephalalgias are the closest mimics. Paroxysmal hemicrania causes shorter, more frequent unilateral autonomic attacks and has an absolute response to indometacin when correctly tested. SUNCT and SUNA are far briefer neuralgiform attacks, often seconds to minutes, and can occur many times daily. Hemicrania continua is continuous unilateral pain with exacerbations and an indometacin response. These distinctions change treatment, so a trial should be specialist-supervised rather than improvised from an examination mnemonic.
Migraine may be unilateral and can have autonomic symptoms, but usually lasts much longer and patients commonly prefer stillness. Trigeminal neuralgia is brief, electric shock-like facial pain with triggers; it lacks the typical 15-to-180-minute severe attack pattern. Acute angle-closure glaucoma can cause headache, red painful eye, blurred or misty vision, halos, nausea and a semi-dilated pupil; it is an eye emergency, not cluster headache. Sinus, dental and temporomandibular disease are considered when local findings support them, but nasal congestion alone is not evidence of sinusitis.
Secondary causes require particular caution with an unusual age at onset, persistent Horner syndrome between attacks, abnormal neurology, visual symptoms, systemic illness, immunosuppression, malignancy, trauma, pregnancy or a substantial change in an established pattern. Carotid dissection, aneurysm, cavernous sinus processes, pituitary lesions, infection and orbital pathology can mimic a trigeminal autonomic cephalalgia. The safe differential is a reasoned urgent work-up, not a long list that delays analgesia, eye review or imaging when needed.
Management
Treat the attack promptly and build a plan before the next one. Current guidelines recommends 100% oxygen at at least 12 L/minute through a non-rebreathing mask with reservoir bag, and/or a subcutaneous or nasal triptan. The appropriate choice depends on diagnosis, contraindications, attack frequency, past response, pregnancy, cardiovascular risk and local availability. Oral triptans, paracetamol, non-steroidal anti-inflammatory drugs, opioids and ergots should not be offered for acute cluster headache under current guidelines guidance because their onset is too slow or their risk-benefit profile is unsuitable. Oxygen must be prescribed and supplied as medical oxygen with fire safety instruction; never substitute industrial oxygen.
Preventive treatment usually begins during an active bout after specialist input. Current guidelines advises considering verapamil and seeking specialist advice before starting it if the clinician is unfamiliar, including advice on ECG monitoring. A specialist may use transitional treatment or other preventives in selected cases, but choice, dose, duration and monitoring are not safely transferable from a web guide. Record baseline pulse, blood pressure, ECG, comorbidity and interacting drugs. Reassess whether the cluster bout has ended so that unnecessary preventive exposure does not continue.
A diary should capture attack timing, treatment, response, adverse effects and possible personal triggers. Avoid alcohol during an active bout if it reliably triggers attacks. Offer smoking cessation, sleep assessment when indicated, occupational advice and psychological support. Explain the emergency plan to family members. Repeated emergency attendance, inability to obtain oxygen, triptan overuse, treatment failure or distress with self-harm thoughts needs urgent clinical escalation, not reassurance alone.
Prescribing Information
Subcutaneous and nasal triptans are prescription medicines with important contraindications and maximum daily doses that depend on the specific product. Before prescribing, assess known coronary, cerebrovascular or peripheral vascular disease, uncontrolled hypertension, hemiplegic or basilar migraine history where relevant, serious hepatic impairment, interacting serotonergic medicines and recent ergot or triptan use. Chest, neck or throat pressure after a triptan requires clinical assessment; severe chest pain or focal neurological symptoms are emergencies. Do not create an unofficial higher-dose schedule simply because attacks are frequent. Follow the Indian product information, specialist plan and pharmacy advice.
Verapamil for cluster prevention is specialist-led and commonly outside a product's licensed headache indication in some jurisdictions. It can cause bradycardia, hypotension, constipation, ankle oedema and conduction abnormalities. Baseline and follow-up ECG monitoring are important because dose-related heart block can occur; the exact protocol should come from the treating service. Review interactions, especially beta-blockers, other rate-limiting drugs and medicines affected by CYP pathways. Stop or adjust only with prescriber guidance, because abrupt changes can destabilise cardiovascular treatment.
Medical oxygen is a drug-like treatment even though it is not a tablet. Teach cylinder storage, regulator use, the non-rebreathing mask and fire precautions. Oxygen is hazardous near flames, smoking and some oils or greases. Access in India is variable across hospitals and home suppliers; the clinician should document the delivery route, written instructions and backup plan. Pregnancy, breastfeeding, adolescents and major cardiac disease require individual specialist advice because evidence, licensing and risk differ. This guide intentionally gives no personalised dose or taper schedule.
When to Refer
Refer a first suspected cluster headache promptly to neurology, a headache clinic or a clinician with demonstrable headache expertise for diagnostic confirmation, imaging decisions and a written acute-and-preventive plan. The need is greater when attacks are atypical, continuous, treatment resistant, recurrent after a new pattern change, or associated with persistent neurological or eye signs. A first bout is a reasonable trigger to discuss imaging even if the examination is normal; the decision should be documented rather than assumed to be unnecessary.
Urgent same-day assessment is appropriate for painful red eye with visual disturbance, new Horner syndrome, focal deficit, altered consciousness, thunderclap onset, fever or meningism, immunosuppression, cancer history, pregnancy/postpartum concerns, head injury or suspected dissection. Refer to ophthalmology for suspected acute angle-closure glaucoma or other ocular disease; dental or ENT referral follows objective local findings, not autonomic nasal symptoms alone. Cardiology review may be needed before or during verapamil treatment when ECG abnormalities, syncope, bradycardia or complex cardiovascular disease are present.
Escalate to specialist headache care for failure of oxygen and appropriate triptans, contraindicated acute treatment, chronic cluster headache, frequent bouts, pregnancy, complex comorbidity, medication overuse, significant functional collapse or suicidal thinking. In India, referral pathways and access differ by district and insurance status. The safe plan identifies a named public or private facility, transport, emergency contact and affordability barriers; it does not promise a device, drug or intervention that the local system cannot supply.
Red Flags
Do not diagnose a primary cluster headache until dangerous alternatives have been considered. Seek emergency assessment for thunderclap onset; new focal weakness, numbness, speech disturbance, seizure or reduced consciousness; fever, neck stiffness, purpura or systemic toxicity; or severe headache after trauma. New eye pain with a red eye, halos, decreased vision, vomiting or a semi-dilated pupil suggests acute angle-closure glaucoma and needs immediate ophthalmic care. A painful partial Horner syndrome, neck pain or transient ischaemic symptoms may indicate carotid dissection.
Escalate urgently for a new or majorly altered unilateral autonomic headache with cancer, immunosuppression, pregnancy or postpartum state, anticoagulation, age over 50 with systemic symptoms, jaw claudication or scalp tenderness, or a persistently abnormal neurological examination. Persistent ptosis or miosis between attacks, ophthalmoplegia, papilloedema, persistent visual change or endocrine symptoms also merit urgent specialist assessment because orbital, cavernous sinus or pituitary disease may mimic a trigeminal autonomic cephalalgia.
There are also treatment red flags. Stop using a planned self-management pathway and seek advice for severe chest pain, syncope, marked breathlessness, new palpitations or slow pulse on preventive therapy; suspected triptan adverse reaction; oxygen-equipment malfunction; or inability to stay safe because of pain or suicidal thoughts. Severe cluster pain can be psychologically overwhelming. Asking directly about safety is a clinical duty, not a judgement about character. Emergency referral should run in parallel with supportive analgesia and communication with family.
Indian Clinical Context
ICHD-3 is an international classification and international guidelines is a United Kingdom guideline; neither automatically determines Indian drug licences, formulary coverage, oxygen reimbursement or referral practice. In India, confirm the current Central Drugs Standard Control Organisation-approved product information, local hospital formulary, state oxygen-supply arrangements and clinician scope before copying a treatment plan. The evidence base has relatively little India-specific trial data, so figures on prevalence, diagnostic delay and response should not be presented as national facts without a cited Indian dataset.
Access is a clinical issue. High-flow medical oxygen, non-rebreathing masks, cylinder refill, emergency transport and injectable triptans may be easy to obtain in one city and inaccessible in another. The plan should name where oxygen can be issued, how equipment will be maintained, who can teach use, what happens during an attack away from home and how the patient will obtain review. A pharmacy purchase without a diagnosis or cardiovascular screen is unsafe. Industrial oxygen, improvised regulators and sharing cylinders are unsafe substitutions.
India-facing care also requires language-concordant counselling and attention to cost, work disruption and family responsibility. A symptom diary can be paper-based and translated. Explain that ordinary painkillers and oral triptans are usually too slow for this attack pattern, rather than implying that the patient has failed morally. NMC training supports history-taking, neurological and ocular assessment, emergency triage, rational prescribing and referral, but the exact competency code should be checked against the currently adopted institutional curriculum. This draft is educational and has been reviewed by the MedNext Clinical Team.
NMC Competency Mapping
This topic maps to undergraduate learning outcomes in medicine and allied clinical postings rather than to an invented single NMC code. Learners should take a structured headache history; distinguish a primary trigeminal autonomic cephalalgia from migraine, neuralgia, ocular emergency and secondary headache; perform focused neurological, ocular and autonomic examination; and formulate a safe initial differential. They should recognise that classification criteria inform, but do not replace, clinical judgement and safety-netting.
At a Know and Know How level, the student should state the characteristic cluster attack duration, frequency range, ipsilateral autonomic features and behavioural restlessness, and explain episodic versus chronic patterns. At a Show How level, the learner can use a headache diary, counsel on red flags, check a prescription for contraindications, demonstrate oxygen fire-safety principles in simulation and communicate an urgent referral. Prescribing itself remains supervised and must use the local formulary, label and monitoring pathway.
Assessment can use a vignette with unilateral orbital pain, tearing and pacing, then ask for discriminating history, differential diagnoses, urgency, immediate treatment class and plan for ECG-monitored prevention. A second vignette should test acute angle-closure glaucoma or carotid dissection so that pattern recognition does not create dangerous anchoring. Professionalism includes validating severe pain, avoiding stigmatizing labels such as drug-seeking, checking mental-health safety and recognising resource constraints. The published NMC Graduate Medical Education Regulations and competency documents should be consulted locally for the current institutional mapping and assessment language.
Key Exam Pearls for NEET PG
Cluster headache is a trigeminal autonomic cephalalgia: severe unilateral orbital, supraorbital or temporal pain lasts 15 to 180 minutes untreated, occurs from one every other day to eight times daily, and is paired with ipsilateral autonomic signs or restlessness. The patient is often agitated or pacing, whereas migraine commonly leads to lying still. At least five attacks and no better diagnosis are required by ICHD-3. Episodic disease has remission of at least three months; chronic disease has no remission, or remission shorter than three months, for at least a year.
The rapid acute options are high-flow 100% oxygen through a non-rebreathing mask with reservoir and a non-oral triptan. Current guidelines specifies at least 12 L/minute for oxygen. Oral analgesics, oral triptans, opioids and ergots are poor acute choices for cluster attacks because onset is too slow or risk is unfavourable. Verapamil is a common preventive option but needs specialist advice and ECG monitoring; do not answer a question as though it is risk-free.
Differentiate paroxysmal hemicrania by shorter, more frequent attacks and indometacin responsiveness; SUNCT/SUNA by seconds-to-minutes neuralgiform attacks; and hemicrania continua by continuous unilateral pain. Painful red eye with blurred vision and a semi-dilated pupil suggests acute angle-closure glaucoma. Persistent Horner syndrome, focal deficit, thunderclap onset or major pattern change requires investigation for a secondary cause. In examinations and practice, a classification diagnosis never cancels emergency triage.
Frequently Asked Questions
Can ordinary painkillers stop a typical cluster headache attack?
Usually not reliably. A cluster attack reaches severe intensity and resolves quickly enough that paracetamol, common anti-inflammatory medicines and oral triptans often act too late. Current guidelines recommends high-flow medical oxygen with a non-rebreathing mask and/or a non-oral triptan after an individual clinical assessment. Do not borrow injections, use industrial oxygen or exceed a prescribed triptan limit; chest symptoms, vascular disease and drug interactions need medical review.
Does a watering eye and blocked nose prove cluster headache?
No. Those symptoms are common autonomic features during cluster headache but can occur in other headache disorders and in eye, sinus or orbital disease. The diagnosis depends on the complete repeated pattern: severe one-sided pain, short stereotyped attacks, characteristic frequency, ipsilateral signs or restlessness, and exclusion of a better explanation. Red eye with reduced vision, halos, vomiting or a semi-dilated pupil needs urgent ophthalmic assessment.
Why are ECG checks needed before and during verapamil treatment?
Verapamil can slow cardiac conduction and cause bradycardia, low blood pressure or heart block, especially as treatment changes. Cluster-headache prevention should therefore have a specialist-led plan with baseline and follow-up ECG monitoring according to the treating service, plus review of other rate-limiting medicines and cardiac history. Patients should report fainting, marked dizziness, breathlessness, new palpitations or unusually slow pulse rather than adjusting doses themselves.
Is cluster headache managed the same way everywhere in India?
No. ICHD-3 classification and international guidelines inform care, but Indian product licensing, hospital formulary restrictions, home oxygen procedures, availability and affordability differ. A useful plan names the local neurology or emergency service, the authorised medical-oxygen supplier, safe device training and a fallback route when supplies fail. This guide cannot promise that a particular formulation, device or specialist intervention is locally accessible.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic